Brain Tumor Epidemiology – A Hub within Multidisciplinary Neuro-oncology. Report on the 15th Brain Tumor Epidemiology Consortium (BTEC) Annual Meeting, Vienna, 2014
Authors:
- Adelheid WoehrerAWAdelheid Woehrer
- Ching C. LauCLChing C. Lau
- Daniela PrayerDPDaniela Prayer
- Luc BauchetLBLuc Bauchet
- Myrna RosenfeldMRMyrna Rosenfeld
- David CapperDCDavid Capper
- Paul G. FisherPFPaul G. Fisher
- Marcel KoolMKMarcel Kool
- Johan M. KrosJohan M. Kros
- Carol KruchkoCKCarol Kruchko
- Joseph WiemelsJWJoseph Wiemels
Open Access
- 1 January 2015
- journal article
- Published by Dustri-Verlag Dr. Karl Feistle in Clinical Neuropathology
- Vol. 34 (01) , 40-46
Abstract
The Brain Tumor Epidemiology Consortium (BTEC) is an open scientific forum, which fosters the development of multi-center, international and inter-disciplinary collaborations. BTEC aims to develop a better understanding of the etiology, outcomes, and prevention of brain tumors (http://epi.grants.cancer.gov/btec/). The 15th annual Brain Tumor Epidemiology Consortium Meeting, hosted by the Austrian Societies of Neuropathology and Neuro-oncology, was held on September 9 - 11, 2014 in Vienna, Austria. The meeting focused on the central role of brain tumor epidemiology within multidisciplinary neuro-oncology. Knowledge of disease incidence, outcomes, as well as risk factors is fundamental to all fields involved in research and treatment of patients with brain tumors; thus, epidemiology constitutes an important link between disciplines, indeed the very hub. This was reflected by the scientific program, which included various sessions linking brain tumor epidemiology with clinical neuro-oncology, tissue-based research, and cancer registration. Renowned experts from Europe and the United States contributed their personal perspectives stimulating further group discussions. Several concrete action plans evolved for the group to move forward until next year's meeting, which will be held at the Mayo Clinic at Rochester, MN, USA.Keywords
This publication has 18 references indexed in Scilit:
- Novel somatic and germline mutations in intracranial germ cell tumoursNature, 2014
- Assessment and treatment relevance in elderly glioblastoma patientsNeuro-Oncology, 2014
- Cytogenetic Prognostication Within Medulloblastoma SubgroupsJournal of Clinical Oncology, 2014
- Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened InhibitionCancer Cell, 2014
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed GlioblastomaNew England Journal of Medicine, 2014
- The Somatic Genomic Landscape of GlioblastomaCell, 2013
- Functional imaging: where do we go from here?2013
- Grading of Gliomas: The Road From Eminence to EvidenceJournal of Neuropathology & Experimental Neurology, 2011
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005